These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8944834)
1. Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex. Kairemo KJ; Ramsay HA; Paavonen T; Bondestam S Eur J Cancer B Oral Oncol; 1996 Sep; 32B(5):311-21. PubMed ID: 8944834 [TBL] [Abstract][Full Text] [Related]
2. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer. Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289 [TBL] [Abstract][Full Text] [Related]
3. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects. Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096 [TBL] [Abstract][Full Text] [Related]
4. Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy. Kairemo KJ; Ramsay HA; Paavonen TK; Jääskelä-Saari HA; Tagesson M; Ljunggren K; Strand SE Cancer Detect Prev; 1997; 21(1):83-90. PubMed ID: 9043768 [TBL] [Abstract][Full Text] [Related]
5. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines. Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815 [TBL] [Abstract][Full Text] [Related]
6. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies. Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R Acta Otolaryngol Suppl; 1997; 529():241-4. PubMed ID: 9288321 [TBL] [Abstract][Full Text] [Related]
7. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice. Jääskelä-Saari HA; Grénman R; Ramsay HA; Tarkkanen J; Paavonen T; Kairemo KJ Cancer Biother Radiopharm; 2005 Aug; 20(4):426-35. PubMed ID: 16114991 [TBL] [Abstract][Full Text] [Related]
8. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC. Hou DY; Hamburger AW; Beach JL; Maruyama Y Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533 [TBL] [Abstract][Full Text] [Related]
10. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals. Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427 [TBL] [Abstract][Full Text] [Related]
11. Assessment of cobalt 57 tagged bleomycin as a clinical aid in staging of head and neck carcinoma. Cummings CW; Larson SM; Dobie RA; Weymuller EA; Rudd TG; Merello A Laryngoscope; 1981 Apr; 91(4):529-37. PubMed ID: 6163936 [TBL] [Abstract][Full Text] [Related]
12. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex. Hou DY; Maruyama Y J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949 [TBL] [Abstract][Full Text] [Related]
13. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy. Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055 [TBL] [Abstract][Full Text] [Related]
15. Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results. Brink I; Klenzner T; Krause T; Mix M; Ross UH; Moser E; Nitzsche EU Nuklearmedizin; 2002 Apr; 41(2):108-13. PubMed ID: 11989297 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020 [TBL] [Abstract][Full Text] [Related]